Barings’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-23,524
Closed -$5M 1035
2014
Q4
$5M Sell
23,524
-2,140
-8% -$426K 0.11% 137
2014
Q3
$4.57M Buy
25,664
+3,830
+18% +$636K 0.1% 144
2014
Q2
$3.69M Buy
21,834
+12,148
+125% +$1.89M 0.11% 188
2014
Q1
$1.2M Sell
9,686
-5,010
-34% -$610K 0.04% 411
2013
Q4
$1.63M Buy
14,696
+400
+3% +$38.2K 0.07% 310
2013
Q3
$1.29M Sell
14,296
-4,200
-23% -$377K 0.06% 371
2013
Q2
$1.56M Buy
+18,496
New +$1.92M 0.07% 301

Other funds holding AGN

Barings's AGN Position: Q1 2015 in Review

Barings sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 23,524 shares — an estimated $5M sold.

Barings first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Barings reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Barings sold 23,524 Allergan Inc shares in Q1 2015, an estimated $5M.
  • Barings first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Barings's Allergan Inc position peaked at $5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Barings's 13F filing for Q1 2015, filed 8 May 2015.